Sijunzi decoction alleviates cancer cachexia myatrophy by suppressing M2 polarization of tumor-associated macrophages via the MCT1/lactate/H3K18 lactylation pathway
- 7 March 2026
- journal article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 364, 121500
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Oligosaccharides and small molecule components of Sijunzi decoction modulate the gut microbiota-bile acid axis to synergistically alleviate spleen deficiency syndromeJournal of Ethnopharmacology, 2025
- Lactylation in tumor microenvironment and immunotherapy resistance: New mechanisms and challengesCancer Letters, 2025
- Sijunzi decoction improves lipid metabolism via regulation of Wnt/β-catenin signaling pathway in diabetic mice and 3T3-L1 cellsJournal of Ethnopharmacology, 2025
- Histone lactylation regulates PRKN-Mediated mitophagy to promote M2 Macrophage polarization in bladder cancerInternational Immunopharmacology, 2025
- Cytokines in cancerCancer Cell, 2024
- Sijunzi decoction enhances sensitivity of colon cancer cells to NK cell destruction by modulating P53 expressionJournal of Ethnopharmacology, 2024
- Histone lactylation inhibits RARγ expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signalingCell Reports, 2024
- Molecular mechanisms of cancer cachexia‐related loss of skeletal muscle mass: data analysis from preclinical and clinical studiesJournal of Cachexia, Sarcopenia and Muscle, 2023
- A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse modelJournal of Ethnopharmacology, 2021
- Modified Sijunzi decoction can alleviate cisplatin-induced toxicity and prolong the survival time of cachectic mice by recovering muscle atrophyJournal of Ethnopharmacology, 2019